News & Events
TIBA Annual Report
We are delighted to inform you that we successfully submitted our first annual report to the funders, NIHR on July 17 and now look forward to the funders’ feedback on the report. We would like to thank everyone for their contributions in fulfilling this very essential requirement by the NIHR.
Partner visit to Edinburgh
All the acronyms!!! TIBA stands for Tackling Infections to Benefit Africa. It is also the Swahili word for “to cure infection”. And AGM, well that’s a more common one, no need for explanations there. So, it was time for TIBA’s first annual general meeting. The venue was Durban, South Africa, one of the nine TIBA partner countries. The University of Kwazulu-Natal had been preparing for the meeting for some time. This was quite an undertaking with contributors coming from far afield.
TIBA AGM in Durban, South Africa
Watch a highlights of the TIBA AGM 2018
TIBA would be hosting its first Annual General Meeting in Durban, South Africa on May 29-31. This meeting will bring together all investigators from the ten partner countries as well as stakeholders and associates. This will be a crucial meeting for deciding on how to progress the rest of the TIBA project. Professor Moses Chimbari (TIBA Co-Deputy Ddirector) and the TIBA South African team will be hosting this event.
The TIBA Partnership is organising a two day ‘Advanced Research Ethics Workshop’ at Mendel Training Centre in Harare from 8-9 February 2018. The workshop which is being hosted by the Medical Research Council of Zimbabwe (MRCZ), is supported through a grant from the UK BBSRC GCRF Impact Acceleration Award to the University of Edinburgh in collaboration with the initiative on Tackling Infections to Benefit Africa (TIBA).
Watch a full video of the launch
Around 50 million people could benefit from a new multidisciplinary research programme that is seeking new solutions to neglected tropical diseases and emerging epidemics in Africa.
Teams of scientists from Africa and the UK will pool their expertise to reduce the burden and threats from diseases like malaria, sleeping sickness, schistosomiasis and lymphatic filariasis.
They will seek to translate research into health technologies and policies that benefit vulnerable communities and better prepare and respond to epidemics such as Ebola.